SBIR/STTR Research Award

Preventing Vascular Complications in Type Diabetes Muscle Metabolic Monitoring

Award identifier 6693eb99b9918a3fe2950089c4f538e96cece006e669548925e1165b737b6efeAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$183,142

Program and phase

STTR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Infrared Rx, Inc.
Proposal award date
2017-09-18
Contract end date
2019-09-17
UEI
WCBQFL361VY1
Solicitation number
PA14-059
Topic code
NIDDK

Research abstract

Project Summary Abstract While much has been accomplished in managing hyperglycemia morbidity and mortality in patients with type diabetes T D often results from cardiovascular complications Evidence suggests peripheral artery disease and skeletal muscle mitochondrial dysfunction One reason is the lack of reliable tools to characterize skeletal muscle microcirculation and mitochondrial capacity key elements in regulating effective mobility and insulin use in health and disease Our central hypothesis is that near infrared spectroscopy NIRS based technology can uniquely assess skeletal muscle function in patients with T D because it accounts for macrovascular microvascular and pharmacologic influences on muscle function In addition the attributes of this technology are inherently valuable to the study and care of complications of type diabetes patients because it is safe reliable non invasive and scalable for widespread use To that end we propose the following specific aims Specific Aim we will develop an automated analysis platform for NIRS derived measures of skeletal muscle mitochondrial capacity Specific Aim we will define the value proposition of NIRS based microvascular and mitochondrial assessment Analysis platform validation will include test retest NIRS measurements and comparison measurement of microcirculation and mitochondrial using magnetic resonance imaging MRI and P magnetic resonance spectroscopy MRS Patients with type diabetes n and aged matched healthy subjects n will be evaluated Our value proposition will be defined through customer discovery with internists endocrinologists and cardiologists The endpoint for the second aim will be a detailed testing protocol and fully automated web based analysis program including error analysis and error correction recommendations We will provide beta testing access to the automated analysis product End user data will inform the next phase of product development a fully integrated and automated data acquisition and analysis platform Importantly Infrared Rx Inc will engage the expertise of team members with healthcare software and marketing expertise to drive the customer discovery process The NIRS based technology is noninvasive inexpensive and portable By making the methods simple to perform and obtain results NIRS has the potential to be a clinical evaluation tool for patients with Type Diabetes Project Narrative Type Diabetes results in impairments in vascular and mitochondrial function which contributes to progression of the disease and poor health outcomes We will develop an automated analysis platform and define the value proposition for NIRS based microvascular and mitochondrial assessments in patients with Type Diabetes

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2017–2021). Reported award amounts total $1,784,593. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.